507
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Tianeptine Abuse and Dependence in Psychiatric Patients: A Review of 18 Case Reports in the Literature

&
Pages 275-280 | Received 30 Jun 2017, Accepted 27 Nov 2017, Published online: 01 Mar 2018

References

  • Anand, J. S., B. Habrat, M. Sut, and R. Korolkiewicz. 2008. Misuse of substances theoretically without abuse potential: Case series. Przegląd Lekarski 66 (6):290–92.
  • Ari, M., S. Oktar, and M. Duru. 2010. Amitriptyline and tianeptine poisoning treated by naloxone. Human & Experimental Toxicology 29 (9):793–95. doi:10.1177/0960327110372403.
  • Bence, C., A. Bonord, C. Rebillard, P. Vaast, C. Alexandre, R. Jardri, and B. Rolland. 2016. Neonatal abstinence syndrome following tianeptine dependence during pregnancy. Pediatrics 137 (1):1–4. doi:10.1542/peds.2015-1414.
  • Bernard, K., P. F. Penelaud, E. Mocaër, and Y. Donazzolo. 2011. Absence of psychostimulant effects of a supratherapeutic dose of tianeptine: A placebo-controlled study versus methylphenidate in young healthy volunteers. Journal of Clinical Psychopharmacology 31 (4):441–48. doi:10.1097/JCP.0b013e3182217a50.
  • Dempsey, S. K., J. L. Poklis, K. Sweat, K. Cumpston, and C. E. Wolf. 2017. Acute toxicity from intravenous use of the tricyclic antidepressant tianeptine. Journal of Analytical Toxicology 41 (6): 547–550.
  • Drugs.com. Tianeptine brand names. https://www.drugs.com/international/tianeptine.html (accessed October 11, 2017).
  • Durmus, N., G. Ozbilen, Y. Kasap, O. Koyuncu, O. Yildirim, G. Artiran, S. Kerman, and D. Aydinkarahaliloglu. 2013. Risk management in tianeptine abuse in Turkey: A national experience. Klinik Psikofarmakoloji Bulteni: Bulletin of Clinical Psychopharmacology 23 (2):149–54. doi:10.5455/bcp.20130426010958.
  • Ferreira, M. J., E. V. Costa, L. Fonseca, C. Pissarra, and J. C. Oliveira. 2008. Abuse of tianeptine: A case report. European Psychiatry 23:S308–S309. doi:10.1016/j.eurpsy.2008.01.1060.
  • Gassaway, M. M., M. L. Rives, A. C. Kruegel, J. A. Javitch, and D. Sames. 2014. The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist. Translational Psychiatry 4:e411. doi:10.1038/tp.2014.30.
  • Guillem, E., and J. P. Lepine. 2002. Does addiction to antidepressants exist? About a case of one addiction to tianeptine. L’Encephale 29 (5):456–59.
  • Hua, C., A. Lagoutte, L. Theveniaud, J.-F. Cannard, L. Dalle, C. Meyer, J.-M. Petit, V. Jost, and M.-H. Guignard. 2007. Withdrawal of a patient addicted to tianeptine: Collaboration between doctors, psychiatrists and pharmacists. Paper presented at the 7th Annual Spring Conference of the European Society of Clinical Pharmacy, Edinburgh, UK, May 16, 2007, 44 [abstract].
  • Hýža, M. M., and M. M. Čechová. 2015. Abúzus tianeptinu. Psychiatria Pre Prax 16 (4):166–68.
  • Invernizzi, R., L. Pozzi, S. Garattini, and R. Samanin. 1992. Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism. Neuropharmacology 31 (3):221–27. doi:10.1016/0028-3908(92)90171-K.
  • Kisa, C., D. O. Bulbul, C. Aydemir, and E. Goka. 2007. Is it possible to be dependent to tianeptine, an antidepressant? A case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (3):776–78. doi:10.1016/j.pnpbp.2007.01.002.
  • Lapsekili, N., and K. F. Yavuz. 2014. Tianeptine abuse: A case report. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences 27:81–84. doi:10.5350/DAJPN2014270112.
  • Leterme, L., Y. S. Singlan, V. Auclair, R. Le Boisselier, and V. Frimas. 2003. Misuse of tianeptine: Five cases of abuse. Annales de Medecine Interne 154:S58–63.
  • Özer, H., and A. Erol. 2011. Abuse of tianeptine: A case report. Bulletin of Clinical Psychopharmacology 21 (Suppl. 2):19.
  • Proença, P., H. Teixeira, J. Pinheiro, P. V. Monsanto, and D. N. Vieira. 2007. Fatal intoxication with tianeptine (Stablon®). Forensic Science International 170 (2):200–03. doi:10.1016/j.forsciint.2007.03.035.
  • Rouby, F., V. Pradel, E. Frauger, V. Pauly, F. Natali, P. Reggio, X. Thirion, and J. Micallef. 2012. Assessment of abuse of tianeptine from a reimbursement database using “doctor shopping” as an indicator. Fundamental & Clinical Pharmacology 26 (2):286–94. doi:10.1111/j.1472-8206.2010.00906.x.
  • Saatçioğlu, O., R. Erim, and D. Cakmak. 2005. A case of tianeptine abuse. Turk Psikiyatri Dergisi [Turkish Journal of Psychiatry] 17 (1):72–75.
  • Sacchetti, G., I. Bonini, G. C. Waeterloos, and R. Samanin. 1993. Tianeptine raises dopamine and blocks stress-induced noradrenaline release in the rat frontal cortex. European Journal of Pharmacology 236 (2):171–75. doi:10.1016/0014-2999(93)90586-7.
  • Soderman, A. R., and E. M. Unterwald. 2008. Cocaine reward and hyperactivity in the rat: Sites of mu opioid receptor modulation. Neuroscience 154:1506–16. doi:10.1016/j.neuroscience.2008.04.063.
  • Trigo, J. M., E. Martin-Garcia, F. Berrendero, P. Robledo, and R. Maldonado. 2010. The endogenous opioid system: A common substrate in drug addiction. Drug and Alcohol Dependence 108:183–94. doi:10.1016/j.drugalcdep.2009.10.011.
  • Tuglu, C., and O. O. Sahin. 2010. Are antidepressants addictive? A case with tianeptine misuse. Anadolu Psikiyatri Dergisi 11 (2):190–93.
  • Vadachkoria, D., L. Gabunia, K. Gambashidze, N. Pkhaladze, and N. Kuridze. 2009. Addictive potential of tianeptine: The threatening reality. Georgian Medical News 174:92–94.
  • Vandel, P., W. Regina, B. Bonin, D. Sechter, and P. Bizouard. 1998. Abuse of tianeptine: A case report. L’Encephale 25 (6):672–73.
  • Wagstaff, A. J., D. Ormrod, and C. M. Spencer. 2001. Tianeptine. CNS Drugs 15 (3):231–59. doi:10.2165/00023210-200115030-00006.
  • Zubieta, J. K., D. A. Gorelick, R. Stauffer, H. T. Ravert, R. F. Dannals, and J. J. Frost. 1996. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nature Medicine 2:1225–29. doi:10.1038/nm1196-1225.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.